Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anheuser-Busch Cos. Inc.
Anheuser-Busch Says InBev's Attempted Consent Solicitation is Effort to Gain Company for Under-Valued Price
July 27th, 2008
Anheuser-Busch Cos. Inc. (NYSE:BUD) said InBev's announced attempt to seek to replace Anheuser-Busch's existing board of directors with InBev's hand-picked nominees is a self-serving effort by InBev to try to purchase Anheuser-Busch for a price Anheuser-Busch's independent board already has determined to be financially inadequate and not in the best interest of shareholders. Anheuser-Busch shareholders should ask themselves whether the directors selected by InBev would negotiate the best transaction for Anheuser-Busch shareholders, the company said. The preliminary consent solicitation filing was made by InBev in connection with a non-binding,...
Source: Pharma Investments, Ventures & Law Weekly (2008-07-27)
|
